WO2000026362A3 - Proteines de la famille de la stomatine et leur utilisation comme proteines cibles pour le traitement de la douleur - Google Patents

Proteines de la famille de la stomatine et leur utilisation comme proteines cibles pour le traitement de la douleur Download PDF

Info

Publication number
WO2000026362A3
WO2000026362A3 PCT/DE1999/003434 DE9903434W WO0026362A3 WO 2000026362 A3 WO2000026362 A3 WO 2000026362A3 DE 9903434 W DE9903434 W DE 9903434W WO 0026362 A3 WO0026362 A3 WO 0026362A3
Authority
WO
WIPO (PCT)
Prior art keywords
stomatin
proteins
family
pain therapy
target proteins
Prior art date
Application number
PCT/DE1999/003434
Other languages
German (de)
English (en)
Other versions
WO2000026362A2 (fr
Inventor
Anne Gabriele Mannsfeldt
Gary Richard Lewin
Original Assignee
Max Delbrueck Centrum
Anne Gabriele Mannsfeldt
Gary Richard Lewin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum, Anne Gabriele Mannsfeldt, Gary Richard Lewin filed Critical Max Delbrueck Centrum
Publication of WO2000026362A2 publication Critical patent/WO2000026362A2/fr
Publication of WO2000026362A3 publication Critical patent/WO2000026362A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

L'invention concerne la stomatine et de nouvelles protéines de la famille de la stomatine, notamment la N-stomatine contenant 287 acides aminés, son ADNc codant ayant une longueur de 1847 nucléotides. L'invention concerne également leur utilisation comme protéines cibles pour le traitement des douleurs et leur utilisation pour la production d'agents thérapeutiques pour le traitement de la douleur, analgésiques/anesthésiques, pour la constitution de gènes, pour le développement de substances d'importance pharmaceutique et dans kits de diagnostic.
PCT/DE1999/003434 1998-10-30 1999-10-28 Proteines de la famille de la stomatine et leur utilisation comme proteines cibles pour le traitement de la douleur WO2000026362A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19850015.7 1998-10-30
DE1998150015 DE19850015A1 (de) 1998-10-30 1998-10-30 Proteine der Stomatinfamilie und ihre Verwendung als Zielproteine für die Schm erztherapie

Publications (2)

Publication Number Publication Date
WO2000026362A2 WO2000026362A2 (fr) 2000-05-11
WO2000026362A3 true WO2000026362A3 (fr) 2000-06-22

Family

ID=7886124

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/003434 WO2000026362A2 (fr) 1998-10-30 1999-10-28 Proteines de la famille de la stomatine et leur utilisation comme proteines cibles pour le traitement de la douleur

Country Status (2)

Country Link
DE (1) DE19850015A1 (fr)
WO (1) WO2000026362A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2813499B1 (fr) 2000-09-04 2004-11-26 Pasteur Institut Mammifere non-humain mutant pour l'expression de la sous- unite alpha6 du recepteur nicotinique de l'acetylcholine et utilisation pour le criblage de substances susceptibles d'interagir avec ce recepteur
IL151980A0 (en) * 2002-09-29 2003-04-10 Yeda Res & Dev Resistin binding proteins, their preparation and use
AU2003283326A1 (en) * 2002-10-30 2004-05-25 Max-Delbruck-Centrum Fur Molekulare Medizin (Mdc) Berlin-Buch Method for identifying compounds which inhibit mechanotransduction in neurons

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030690A1 (fr) * 1997-01-09 1998-07-16 Incyte Pharmaceuticals, Inc. Nouvelle proteine membranaire humaine
WO1999025825A2 (fr) * 1997-11-13 1999-05-27 Genset ADNc ETENDUS POUR PROTEINES SECRETEES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030690A1 (fr) * 1997-01-09 1998-07-16 Incyte Pharmaceuticals, Inc. Nouvelle proteine membranaire humaine
WO1999025825A2 (fr) * 1997-11-13 1999-05-27 Genset ADNc ETENDUS POUR PROTEINES SECRETEES

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BARNES T M ET AL: "THE CAENORHABDITIS ELEGANS BEHAVIORAL GENE UNC-24 ENCODES A NOVEL BIPARTITE PROTEIN SIMILAR TO BOTH ERYTHROCYTE BAND 7.2 (STOMATIN) AND NONSPECIFIC LIPID TRANSFER PROTEIN", JOURNAL OF NEUROCHEMISTRY,US,NEW YORK, NY, vol. 67, 1 January 1996 (1996-01-01), pages 46 - 55, XP002063568, ISSN: 0022-3042 *
MANNSFELDT, A.G. ET AL.: "Stomatin, a MEC-2 Like Protein, Is Expressed by Mammalian Sensory Neurons", MOL. CELL. NEUROSCI., vol. 13, no. 6, June 1999 (1999-06-01), pages 391 - 404, XP000889811 *
RAJARAM, S. ET AL.: "unc-1: A stomatin homologue controls sensitivity to volatile anesthetics in Caenorhabditis elegans.", PROC, NATL. ACAD. SCI., vol. 95, July 1998 (1998-07-01), pages 8761 - 8766, XP002132341 *
SCHLEGEL W ET AL: "Cloning and analysis of a cDNA encoding the BALB/c murine erythrocyte band 7 integral membrane protein", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES,GB,ELSEVIER SCIENCE PUBLISHERS, BARKING, vol. 178, no. 1, 31 October 1996 (1996-10-31), pages 115 - 118, XP004043348, ISSN: 0378-1119 *
SEIDEL G ET AL: "Molecular cloning of hSLP-1, a novel human brain-specific member of the band 7/MEC-2 family similar to Caenorhabditis elegans UNC-24", GENE,NL,ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, vol. 225, no. 1-2, 28 December 1998 (1998-12-28), pages 23 - 29, XP004153617, ISSN: 0378-1119 *
STEWART G W ET AL: "ISOLATION OF CDNA CODING FOR AN UBIQUITOUS MEMBRANE PROTEIN DEFICIENT IN HIGH NA+, LOW K STOMATOCYTIC ERYTHROCYTES", BLOOD,US,PHILADELPHIA, PA, vol. 79, 1 January 1992 (1992-01-01), pages 1593 - 1601, XP002063567, ISSN: 0006-4971 *

Also Published As

Publication number Publication date
DE19850015A1 (de) 2000-05-04
WO2000026362A2 (fr) 2000-05-11

Similar Documents

Publication Publication Date Title
WO1996034953A3 (fr) Variants de cd16-ii
WO2002074337A8 (fr) Inhibiteurs et/ou antagonistes de proteines hmgb1 destines au traitement de maladies vasculaires
ES2194114T3 (es) Formulaciones liposomicas de mitoxantrona.
CA2257133A1 (fr) Variantes hyperactives de la desoxyribonuclease i humaine
CA2184908A1 (fr) Cathepsine derivee d'osteoclaste humain
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
AU6721998A (en) Therapeutic use of the smr1 protein and active derivatives thereof
WO2001092218A3 (fr) Nouveaux analogues de polyamine a utiliser en tant qu'agents therapeutiques et diagnostiques
WO1999062561A3 (fr) Methode de therapie genique
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
WO1999062939A3 (fr) Glycoproteines dotees de proprietes de mobilisation des lipides et applications therapeutiques
WO2000026362A3 (fr) Proteines de la famille de la stomatine et leur utilisation comme proteines cibles pour le traitement de la douleur
AU6234099A (en) Gene therapy of alzheimer's disease by delivery of an encoded apoliprotein
CA2290739A1 (fr) Nouveaux sels de peptides bpc ayant une activite de protection de l'organisme, procede de preparation correspondant et leur utilisation en therapie
DK0938329T3 (da) Immunogen TLP sammensætning
MXPA02012308A (es) Nuevo interferon para el tratamiento de esclerosis multiple.
CA2210871A1 (fr) Variantes de la dnase i humaine
CA2250433A1 (fr) Dnase ii humaine
AU6690898A (en) Composition for the treatment of exercise induced pulmonary hemorrhage and inhaler for administering said composition
WO2002000822A3 (fr) Nouveau polypeptide, sous-unite humaine 2 $g(b) 16.5 du facteur d'initiation necessaire a la synthese proteique, et polynucleotide codant ce polypeptide
SE9803623D0 (sv) New therapeutic application
WO2002008421A1 (fr) Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide
CA2242562A1 (fr) Dnase humaine resistant a l'inhibition par l'actine
WO2001096526A3 (fr) Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase